via Nano Magazine
HZDR researchers trace cancer cells with tailor-made materials
Modern anticancer therapies aim to attack tumor cells while sparing healthy tissue. An interdisciplinary team of researchers at Helmholtz-Zentrum Dresden-Rossendorf (HZDR) and FU Berlin has made important progress in this area: the scientists have produced tiny nanoparticles that are designed to specifically target cancer cells. They can navigate directly to the tumor cells and visualize those using advanced imaging techniques. Both in petri dishes and animal models, the scientists were able to effectively guide the nanoparticles to the cancer cells. The next step is to combine the new technique with therapeutic approaches.
The HZDR researchers start out with tiny, biocompatible nanoparticles made of so-called dendritic polyglycerols that serve as carrier molecules. “We can modify these particles and introduce various functions,” explains Dr. Kristof Zarschler, research associate at HZDR’s Institute of Radiopharmaceutical Cancer Research. “For example, we can attach an antibody fragment to the particle that specifically binds to cancer cells. This antibody fragment is our targeting moiety that directs the nanoparticle to the tumor.”
The target of the modified nanoparticles is an antigen known as EGFR (epidermal growth factor receptor). In certain types of cancer, such as breast cancer or head and neck tumors, this protein is overexpressed on the surface of the cells. “We were able to show that our designed nanoparticles preferentially interact with the cancer cells via these receptors,” confirms Dr. Holger Stephan, leader of the Nanoscalic Systems Group at HZDR. “In control tests with similar nanoparticles that had been modified with an unspecific antibody, significantly fewer nanoparticles accumulated at the tumor cells.”
The scientists intensively studied the nanoparticles’ behavior both in cell cultures and in an animal model. For this purpose, they provided the nanoparticles with additional reporter characteristics, as Kristof Zarschler explains: “We used two complementary possibilities. In addition to the antibodies, we attached dye molecules and radionuclides to the nanoparticles. The dye molecule emits in the near infrared spectrum that penetrates the tissue and can be visualized with an appropriate microscope. The dye thus reveals where exactly the nanoparticles are located.” The radionuclide, copper-64, fulfils a similar purpose. It emits radiation that is detected by a PET scanner (positron emission tomography). The signals can then be converted into a three-dimensional image that visualizes the distribution of the nanoparticles in the organism.
Excellent properties in living organisms
Using these imaging techniques, researchers have been able to show that nanoparticle accumulation in the tumor tissue reaches maximum two days after administration to mice. The labelled nanoparticles are subsequently eliminated via the kidneys without being a burden for the body. “They are apparently ideal in size and properties,” says Holger Stephan. “Smaller particles are filtered out of the blood in just a few hours and thus only have a short-term impact. If, on the other hand, the particles are too big, they accumulate in the spleen, liver or lungs and cannot be removed from the body via the kidneys and bladder.” The interplay between the nanoparticles with an exact size of three nanometers and the attached antibody fragments evidently has a positive influence on the distribution and retention of the antibody in the organism as well as on its excretion profile.
In future experiments, the HZDR researchers want to test whether they can modify their system to carry other components. Kristof Zarschler describes the plans: “You can take these nanoparticles and functionalize them with an active substance. Then you can deliver a drug directly to the tumor. This might be a therapeutic radionuclide that destroys the tumor cells.” It is also possible to attach antibody fragments specific for proteins other than EGFR to target different types of cancer.
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
- Green synthesis of ZnO nanoparticles decorated on polyindole functionalized-MCNTs and used as anode material for enzymatic biofuel cell applicationson March 19, 2020 at 3:09 am
Recently, enzymatic biofuel cell (EBFC) is a modern green renewable technology that can harness hidden electrical energy present in the chemical bonds of the replicate fuels, while catalyzing them ...
- Exploiting the role of nanoparticle shape in enhancing hydrogel adhesive and mechanical propertieson March 17, 2020 at 3:35 am
The ability to control nanostructure shape and dimensions presents opportunities to design materials in which their macroscopic properties are dependent upon the nature of the nanoparticle. Here the ...
- PCN-222 Metal-Organic Framework Nanoparticles with Tunable Pore Size for Nanocomposite Reverse Osmosis Membraneson March 13, 2020 at 4:43 am
TFN membranes containing PCN-222 nanoparticles modified with varying levels of myristic acid (MA) were fabricated via dispersion in the aqueous phase during interfacial polymerization, and the ...
- Bio-Path Holdings Appoints Ernst & Young as New Auditoron March 12, 2020 at 2:10 am
Bio-Path Holdings, Inc., (BPTH), a biotechnology company leveraging its proprietary DNAbilize® antisense RNAi nanoparticle technology to develop a portfolio of targeted nucleic acid cancer drugs, toda ...
- Can Leptin-derived Sequence-modified Nanoparticles be Suitable Tools for Brain Delivery?on March 2, 2020 at 4:00 pm
Surface Modification of the NPs Both NP-P and TMR-NP-P were modified on the surface according ... stored for further conjugation with thiolated nanoparticles (NP-SH or TMR-NP-SH).
Go deeper with Google Headlines on:
Go deeper with Bing News on:
- Nanomedicine Strategies for Hematological Malignancies: What Is Next?on March 16, 2020 at 5:00 pm
While nanoparticles are usually designed for ...  Non-PEGylated liposomes Myocet® (TEVA, Israel) Biocompatible, amphiphilic; biodegradability; targeting potential; low toxicity Cytarabine ...
- Medicine Innovates Feature: Development of New Stable Biophotonic Imaging Agentson March 16, 2020 at 9:13 am
This press release was orginally distributed by SBWire Ottawa, ON -- ( SBWIRE) -- 03/16/2020 -- The onset of nanotechnology has been of great benefit to the medical field. Lipid nanoparticles have ...
- Killing cancer cells by rupturing their lysosomeson March 16, 2020 at 9:11 am
This cancer treatment approach only involves bio-inert and essentially biocompatible Au nanoparticles. The therapeutic power comes from the aggregation of nanoparticles as triggered by changes to the ...
- Trehalose-Conjugated, Catechin-Loaded Polylactide Nanoparticles for Improved Neuroprotection against Intracellular Polyglutamine Aggregateson March 12, 2020 at 1:37 am
We have recently demonstrated that transforming these antiamyloidogenic small molecules into nanoparticle forms can greatly improve their performance, and biocompatible/biodegradable formulation of ...
- NYU Abu Dhabi researchers design new technology for targeted cancer drug deliveryon March 3, 2020 at 4:00 pm
“We used a simple approach and readily available low-cost materials to prepare biocompatible and biodegradable pH-responsive hybrid nanoparticles for the effective delivery of chemotherapeutics ...